APO Research
Talk to an analyst

APO RESEARCH · REPORT

Circadian Rhythm Sleep Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Circadian Rhythm Sleep Treatment Market Analysis and Forecast 2026-2032

29 December 2025191 pages

Choose your research edition.

Industry ResearchCircadian Rhythm Sleep Treatment Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Circadian Rhythm Sleep Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Circadian Rhythm Sleep Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Circadian Rhythm Sleep Treatment Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Circadian Rhythm Sleep Treatment Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Circadian Rhythm Sleep Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Circadian Rhythm Sleep Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Circadian Rhythm Sleep Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Circadian Rhythm Sleep Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Circadian Rhythm Sleep Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Circadian Rhythm Sleep Treatment include By-Health, GNC, Jameison, Koninklijke Philips, Luminette, Natrol, Nature Made (Pharmavite), NBTY and PEGASI, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Circadian Rhythm Sleep Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Circadian Rhythm Sleep Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Circadian Rhythm Sleep Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Circadian Rhythm Sleep Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Circadian Rhythm Sleep Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Circadian Rhythm Sleep Treatment revenue, projected growth trends, production technology, application and end-user industry.

Circadian Rhythm Sleep Treatment Segment by Company

By-Health

GNC

Jameison

Koninklijke Philips

Luminette

Natrol

Nature Made (Pharmavite)

NBTY

PEGASI

Sleepace

Takeda Pharmaceutical

Vicks (Procter & Gamble)

Teva Pharmaceuticals

Circadian Rhythm Sleep Treatment Segment by Type

Drug Therapy

Light Therapy

Circadian Rhythm Sleep Treatment Segment by Application

Delayed Sleep Phase Syndrome (DSPS)

Advanced Sleep Phase Syndrome (ASPS)

Irregular Sleep-Wake Disorder (ISWD)

Others

Circadian Rhythm Sleep Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Circadian Rhythm Sleep Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Circadian Rhythm Sleep Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Circadian Rhythm Sleep Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Circadian Rhythm Sleep Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Circadian Rhythm Sleep Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Circadian Rhythm Sleep Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Circadian Rhythm Sleep Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Drug Therapy Major Player Table 3. Light Therapy Major Player Table 4. Global Circadian Rhythm Sleep Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Delayed Sleep Phase Syndrome (DSPS) Major Player Table 6. Advanced Sleep Phase Syndrome (ASPS) Major Player Table 7. Irregular Sleep-Wake Disorder (ISWD) Major Player Table 8. Others Major Player Table 9. Circadian Rhythm Sleep Treatment Industry Trends Table 10. Circadian Rhythm Sleep Treatment Industry Drivers Table 11. Circadian Rhythm Sleep Treatment Industry Opportunities and Challenges Table 12. Circadian Rhythm Sleep Treatment Industry Restraints Table 13. Global Circadian Rhythm Sleep Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Circadian Rhythm Sleep Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Circadian Rhythm Sleep Treatment Market Share by Region (2021-2026) Table 16. Global Circadian Rhythm Sleep Treatment Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Circadian Rhythm Sleep Treatment Market Share by Region (2027-2032) Table 18. Global Circadian Rhythm Sleep Treatment Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Circadian Rhythm Sleep Treatment Revenue Market Share by Players (2021-2026) Table 20. Global Circadian Rhythm Sleep Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Circadian Rhythm Sleep Treatment Key Players Headquarters & Area Served Table 22. Global Circadian Rhythm Sleep Treatment Players, Product Type & Application Table 23. Global Circadian Rhythm Sleep Treatment Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Circadian Rhythm Sleep Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Circadian Rhythm Sleep Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Circadian Rhythm Sleep Treatment Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Circadian Rhythm Sleep Treatment Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Circadian Rhythm Sleep Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Circadian Rhythm Sleep Treatment Revenue Market Share by Type (2027-2032) Table 31. Global Circadian Rhythm Sleep Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Circadian Rhythm Sleep Treatment Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Circadian Rhythm Sleep Treatment Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Circadian Rhythm Sleep Treatment Revenue Market Share by Application (2021-2026) Table 35. Global Circadian Rhythm Sleep Treatment Revenue Market Share by Application (2027-2032) Table 36. By-Health Company Information Table 37. By-Health Business Overview Table 38. By-Health Circadian Rhythm Sleep Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. By-Health Circadian Rhythm Sleep Treatment Product Portfolio Table 40. By-Health Recent Development Table 41. GNC Company Information Table 42. GNC Business Overview Table 43. GNC Circadian Rhythm Sleep Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. GNC Circadian Rhythm Sleep Treatment Product Portfolio Table 45. GNC Recent Development Table 46. Jameison Company Information Table 47. Jameison Business Overview Table 48. Jameison Circadian Rhythm Sleep Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Jameison Circadian Rhythm Sleep Treatment Product Portfolio Table 50. Jameison Recent Development Table 51. Koninklijke Philips Company Information Table 52. Koninklijke Philips Business Overview Table 53. Koninklijke Philips Circadian Rhythm Sleep Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Koninklijke Philips Circadian Rhythm Sleep Treatment Product Portfolio Table 55. Koninklijke Philips Recent Development Table 56. Luminette Company Information Table 57. Luminette Business Overview Table 58. Luminette Circadian Rhythm Sleep Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Luminette Circadian Rhythm Sleep Treatment Product Portfolio Table 60. Luminette Recent Development Table 61. Natrol Company Information Table 62. Natrol Business Overview Table 63. Natrol Circadian Rhythm Sleep Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Natrol Circadian Rhythm Sleep Treatment Product Portfolio Table 65. Natrol Recent Development Table 66. Nature Made (Pharmavite) Company Information Table 67. Nature Made (Pharmavite) Business Overview Table 68. Nature Made (Pharmavite) Circadian Rhythm Sleep Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Nature Made (Pharmavite) Circadian Rhythm Sleep Treatment Product Portfolio Table 70. Nature Made (Pharmavite) Recent Development Table 71. NBTY Company Information Table 72. NBTY Business Overview Table 73. NBTY Circadian Rhythm Sleep Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. NBTY Circadian Rhythm Sleep Treatment Product Portfolio Table 75. NBTY Recent Development Table 76. PEGASI Company Information Table 77. PEGASI Business Overview Table 78. PEGASI Circadian Rhythm Sleep Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. PEGASI Circadian Rhythm Sleep Treatment Product Portfolio Table 80. PEGASI Recent Development Table 81. Sleepace Company Information Table 82. Sleepace Business Overview Table 83. Sleepace Circadian Rhythm Sleep Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Sleepace Circadian Rhythm Sleep Treatment Product Portfolio Table 85. Sleepace Recent Development Table 86. Takeda Pharmaceutical Company Information Table 87. Takeda Pharmaceutical Business Overview Table 88. Takeda Pharmaceutical Circadian Rhythm Sleep Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Takeda Pharmaceutical Circadian Rhythm Sleep Treatment Product Portfolio Table 90. Takeda Pharmaceutical Recent Development Table 91. Vicks (Procter & Gamble) Company Information Table 92. Vicks (Procter & Gamble) Business Overview Table 93. Vicks (Procter & Gamble) Circadian Rhythm Sleep Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Vicks (Procter & Gamble) Circadian Rhythm Sleep Treatment Product Portfolio Table 95. Vicks (Procter & Gamble) Recent Development Table 96. Teva Pharmaceuticals Company Information Table 97. Teva Pharmaceuticals Business Overview Table 98. Teva Pharmaceuticals Circadian Rhythm Sleep Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Teva Pharmaceuticals Circadian Rhythm Sleep Treatment Product Portfolio Table 100. Teva Pharmaceuticals Recent Development Table 101. North America Circadian Rhythm Sleep Treatment Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Circadian Rhythm Sleep Treatment Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Circadian Rhythm Sleep Treatment Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Circadian Rhythm Sleep Treatment Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Circadian Rhythm Sleep Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Circadian Rhythm Sleep Treatment Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Circadian Rhythm Sleep Treatment Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Circadian Rhythm Sleep Treatment Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Circadian Rhythm Sleep Treatment Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Circadian Rhythm Sleep Treatment Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Circadian Rhythm Sleep Treatment Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Circadian Rhythm Sleep Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Circadian Rhythm Sleep Treatment Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Circadian Rhythm Sleep Treatment Revenue by Country (US$ Million) & (2027-2032) Table 115. China Circadian Rhythm Sleep Treatment Revenue by Type (2021-2026) & (US$ Million) Table 116. China Circadian Rhythm Sleep Treatment Revenue by Type (2027-2032) & (US$ Million) Table 117. China Circadian Rhythm Sleep Treatment Revenue by Application (2021-2026) & (US$ Million) Table 118. China Circadian Rhythm Sleep Treatment Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Circadian Rhythm Sleep Treatment Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Circadian Rhythm Sleep Treatment Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Circadian Rhythm Sleep Treatment Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Circadian Rhythm Sleep Treatment Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Circadian Rhythm Sleep Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Circadian Rhythm Sleep Treatment Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Circadian Rhythm Sleep Treatment Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Circadian Rhythm Sleep Treatment Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Circadian Rhythm Sleep Treatment Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Circadian Rhythm Sleep Treatment Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Circadian Rhythm Sleep Treatment Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Circadian Rhythm Sleep Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Circadian Rhythm Sleep Treatment Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Circadian Rhythm Sleep Treatment Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Circadian Rhythm Sleep Treatment Image Figure 2. Global Circadian Rhythm Sleep Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Circadian Rhythm Sleep Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Drug Therapy Image Figure 5. Light Therapy Image Figure 6. Global Circadian Rhythm Sleep Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Circadian Rhythm Sleep Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 8. Delayed Sleep Phase Syndrome (DSPS) Image Figure 9. Advanced Sleep Phase Syndrome (ASPS) Image Figure 10. Irregular Sleep-Wake Disorder (ISWD) Image Figure 11. Others Image Figure 12. Global Circadian Rhythm Sleep Treatment Market Size (US$ Million) & (2021-2032) Figure 13. Global Circadian Rhythm Sleep Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Circadian Rhythm Sleep Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Circadian Rhythm Sleep Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Circadian Rhythm Sleep Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Circadian Rhythm Sleep Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Circadian Rhythm Sleep Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Circadian Rhythm Sleep Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Circadian Rhythm Sleep Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Circadian Rhythm Sleep Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Circadian Rhythm Sleep Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Circadian Rhythm Sleep Treatment Revenue Share by Type (2021-2032) Figure 25. North America Circadian Rhythm Sleep Treatment Revenue Share by Application (2021-2032) Figure 26. North America Circadian Rhythm Sleep Treatment Revenue Share by Country (2021-2032) Figure 27. United States Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Circadian Rhythm Sleep Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Circadian Rhythm Sleep Treatment Revenue Share by Type (2021-2032) Figure 32. Europe Circadian Rhythm Sleep Treatment Revenue Share by Application (2021-2032) Figure 33. Europe Circadian Rhythm Sleep Treatment Revenue Share by Country (2021-2032) Figure 34. Germany Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Circadian Rhythm Sleep Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Circadian Rhythm Sleep Treatment Revenue Share by Type (2021-2032) Figure 44. China Circadian Rhythm Sleep Treatment Revenue Share by Application (2021-2032) Figure 45. Asia Circadian Rhythm Sleep Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Circadian Rhythm Sleep Treatment Revenue Share by Type (2021-2032) Figure 47. Asia Circadian Rhythm Sleep Treatment Revenue Share by Application (2021-2032) Figure 48. Asia Circadian Rhythm Sleep Treatment Revenue Share by Region (2021-2032) Figure 49. Japan Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Circadian Rhythm Sleep Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Circadian Rhythm Sleep Treatment Revenue Share by Type (2021-2032) Figure 57. SAMEA Circadian Rhythm Sleep Treatment Revenue Share by Application (2021-2032) Figure 58. SAMEA Circadian Rhythm Sleep Treatment Revenue Share by Country (2021-2032) Figure 59. Brazil Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Circadian Rhythm Sleep Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Drug Therapy
  • Light Therapy
Applications
  • Delayed Sleep Phase Syndrome (DSPS)
  • Advanced Sleep Phase Syndrome (ASPS)
  • Irregular Sleep-Wake Disorder (ISWD)
  • Others
Companies covered
  • By-Health
  • GNC
  • Jameison
  • Koninklijke Philips
  • Luminette
  • Natrol
  • Nature Made (Pharmavite)
  • NBTY
  • PEGASI
  • Sleepace
  • Takeda Pharmaceutical
  • Vicks (Procter & Gamble)
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Circadian Rhythm Sleep Treatment Market by Type
  3. 1.2.1 Global Circadian Rhythm Sleep Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Drug Therapy
  5. 1.2.3 Light Therapy
  6. 1.3 Circadian Rhythm Sleep Treatment Market by Application
  7. 1.3.1 Global Circadian Rhythm Sleep Treatment Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Delayed Sleep Phase Syndrome (DSPS)
  9. 1.3.3 Advanced Sleep Phase Syndrome (ASPS)
  10. 1.3.4 Irregular Sleep-Wake Disorder (ISWD)
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Circadian Rhythm Sleep Treatment Market Dynamics
  1. 2.1 Circadian Rhythm Sleep Treatment Industry Trends
  2. 2.2 Circadian Rhythm Sleep Treatment Industry Drivers
  3. 2.3 Circadian Rhythm Sleep Treatment Industry Opportunities and Challenges
  4. 2.4 Circadian Rhythm Sleep Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Circadian Rhythm Sleep Treatment Market Perspective (2021-2032)
  2. 3.2 Global Circadian Rhythm Sleep Treatment Growth Trends by Region
  3. 3.2.1 Global Circadian Rhythm Sleep Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Circadian Rhythm Sleep Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Circadian Rhythm Sleep Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Circadian Rhythm Sleep Treatment Revenue by Players
  2. 4.1.1 Global Circadian Rhythm Sleep Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Circadian Rhythm Sleep Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Circadian Rhythm Sleep Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Circadian Rhythm Sleep Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Circadian Rhythm Sleep Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Circadian Rhythm Sleep Treatment Players, Product Type & Application
  8. 4.5 Global Circadian Rhythm Sleep Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Circadian Rhythm Sleep Treatment Market CR5 and HHI
  11. 4.6.3 2025 Circadian Rhythm Sleep Treatment Tier 1, Tier 2, and Tier 3
5 Circadian Rhythm Sleep Treatment Market Size by Type
  1. 5.1 Global Circadian Rhythm Sleep Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Circadian Rhythm Sleep Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Circadian Rhythm Sleep Treatment Revenue Market Share by Type (2021-2032)
6 Circadian Rhythm Sleep Treatment Market Size by Application
  1. 6.1 Global Circadian Rhythm Sleep Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Circadian Rhythm Sleep Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Circadian Rhythm Sleep Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 By-Health
  2. 7.1.1 By-Health Company Information
  3. 7.1.2 By-Health Business Overview
  4. 7.1.3 By-Health Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 By-Health Circadian Rhythm Sleep Treatment Product Portfolio
  6. 7.1.5 By-Health Recent Developments
  7. 7.2 GNC
  8. 7.2.1 GNC Company Information
  9. 7.2.2 GNC Business Overview
  10. 7.2.3 GNC Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 GNC Circadian Rhythm Sleep Treatment Product Portfolio
  12. 7.2.5 GNC Recent Developments
  13. 7.3 Jameison
  14. 7.3.1 Jameison Company Information
  15. 7.3.2 Jameison Business Overview
  16. 7.3.3 Jameison Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Jameison Circadian Rhythm Sleep Treatment Product Portfolio
  18. 7.3.5 Jameison Recent Developments
  19. 7.4 Koninklijke Philips
  20. 7.4.1 Koninklijke Philips Company Information
  21. 7.4.2 Koninklijke Philips Business Overview
  22. 7.4.3 Koninklijke Philips Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Koninklijke Philips Circadian Rhythm Sleep Treatment Product Portfolio
  24. 7.4.5 Koninklijke Philips Recent Developments
  25. 7.5 Luminette
  26. 7.5.1 Luminette Company Information
  27. 7.5.2 Luminette Business Overview
  28. 7.5.3 Luminette Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Luminette Circadian Rhythm Sleep Treatment Product Portfolio
  30. 7.5.5 Luminette Recent Developments
  31. 7.6 Natrol
  32. 7.6.1 Natrol Company Information
  33. 7.6.2 Natrol Business Overview
  34. 7.6.3 Natrol Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Natrol Circadian Rhythm Sleep Treatment Product Portfolio
  36. 7.6.5 Natrol Recent Developments
  37. 7.7 Nature Made (Pharmavite)
  38. 7.7.1 Nature Made (Pharmavite) Company Information
  39. 7.7.2 Nature Made (Pharmavite) Business Overview
  40. 7.7.3 Nature Made (Pharmavite) Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Nature Made (Pharmavite) Circadian Rhythm Sleep Treatment Product Portfolio
  42. 7.7.5 Nature Made (Pharmavite) Recent Developments
  43. 7.8 NBTY
  44. 7.8.1 NBTY Company Information
  45. 7.8.2 NBTY Business Overview
  46. 7.8.3 NBTY Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 NBTY Circadian Rhythm Sleep Treatment Product Portfolio
  48. 7.8.5 NBTY Recent Developments
  49. 7.9 PEGASI
  50. 7.9.1 PEGASI Company Information
  51. 7.9.2 PEGASI Business Overview
  52. 7.9.3 PEGASI Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 PEGASI Circadian Rhythm Sleep Treatment Product Portfolio
  54. 7.9.5 PEGASI Recent Developments
  55. 7.10 Sleepace
  56. 7.10.1 Sleepace Company Information
  57. 7.10.2 Sleepace Business Overview
  58. 7.10.3 Sleepace Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Sleepace Circadian Rhythm Sleep Treatment Product Portfolio
  60. 7.10.5 Sleepace Recent Developments
  61. 7.11 Takeda Pharmaceutical
  62. 7.11.1 Takeda Pharmaceutical Company Information
  63. 7.11.2 Takeda Pharmaceutical Business Overview
  64. 7.11.3 Takeda Pharmaceutical Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Takeda Pharmaceutical Circadian Rhythm Sleep Treatment Product Portfolio
  66. 7.11.5 Takeda Pharmaceutical Recent Developments
  67. 7.12 Vicks (Procter & Gamble)
  68. 7.12.1 Vicks (Procter & Gamble) Company Information
  69. 7.12.2 Vicks (Procter & Gamble) Business Overview
  70. 7.12.3 Vicks (Procter & Gamble) Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Vicks (Procter & Gamble) Circadian Rhythm Sleep Treatment Product Portfolio
  72. 7.12.5 Vicks (Procter & Gamble) Recent Developments
  73. 7.13 Teva Pharmaceuticals
  74. 7.13.1 Teva Pharmaceuticals Company Information
  75. 7.13.2 Teva Pharmaceuticals Business Overview
  76. 7.13.3 Teva Pharmaceuticals Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Teva Pharmaceuticals Circadian Rhythm Sleep Treatment Product Portfolio
  78. 7.13.5 Teva Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Circadian Rhythm Sleep Treatment Revenue (2021-2032)
  2. 8.2 North America Circadian Rhythm Sleep Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Circadian Rhythm Sleep Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Circadian Rhythm Sleep Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Circadian Rhythm Sleep Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Circadian Rhythm Sleep Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Circadian Rhythm Sleep Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Circadian Rhythm Sleep Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Circadian Rhythm Sleep Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Circadian Rhythm Sleep Treatment Revenue by Country
  11. 8.6.1 North America Circadian Rhythm Sleep Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Circadian Rhythm Sleep Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Circadian Rhythm Sleep Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Circadian Rhythm Sleep Treatment Revenue (2021-2032)
  2. 9.2 Europe Circadian Rhythm Sleep Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Circadian Rhythm Sleep Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Circadian Rhythm Sleep Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Circadian Rhythm Sleep Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Circadian Rhythm Sleep Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Circadian Rhythm Sleep Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Circadian Rhythm Sleep Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Circadian Rhythm Sleep Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Circadian Rhythm Sleep Treatment Revenue by Country
  11. 9.6.1 Europe Circadian Rhythm Sleep Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Circadian Rhythm Sleep Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Circadian Rhythm Sleep Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Circadian Rhythm Sleep Treatment Revenue (2021-2032)
  2. 10.2 China Circadian Rhythm Sleep Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Circadian Rhythm Sleep Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Circadian Rhythm Sleep Treatment Revenue by Type (2027-2032)
  5. 10.3 China Circadian Rhythm Sleep Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Circadian Rhythm Sleep Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Circadian Rhythm Sleep Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Circadian Rhythm Sleep Treatment Revenue by Application (2027-2032)
  9. 10.5 China Circadian Rhythm Sleep Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Circadian Rhythm Sleep Treatment Revenue (2021-2032)
  2. 11.2 Asia Circadian Rhythm Sleep Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Circadian Rhythm Sleep Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Circadian Rhythm Sleep Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Circadian Rhythm Sleep Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Circadian Rhythm Sleep Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Circadian Rhythm Sleep Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Circadian Rhythm Sleep Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Circadian Rhythm Sleep Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Circadian Rhythm Sleep Treatment Revenue by Country
  11. 11.6.1 Asia Circadian Rhythm Sleep Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Circadian Rhythm Sleep Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Circadian Rhythm Sleep Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Circadian Rhythm Sleep Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Circadian Rhythm Sleep Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Circadian Rhythm Sleep Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Circadian Rhythm Sleep Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Circadian Rhythm Sleep Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Circadian Rhythm Sleep Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Circadian Rhythm Sleep Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Circadian Rhythm Sleep Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Circadian Rhythm Sleep Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Circadian Rhythm Sleep Treatment Revenue by Country
  11. 12.6.1 SAMEA Circadian Rhythm Sleep Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Circadian Rhythm Sleep Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Circadian Rhythm Sleep Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst